David Zaccardelli - 26 Sep 2022 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
President and CEO, Director
Signature
/s/ Claire Poll, Attorney-in-fact for David Zaccardelli
Issuer symbol
VRNA
Transactions as of
26 Sep 2022
Net transactions value
$0
Form type
4
Filing time
28 Sep 2022, 16:05:57 UTC
Previous filing
11 Aug 2022
Next filing
03 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Award $0 +3,600,000 +24% $0.000000 18,863,560 26 Sep 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents an award of Restricted Share Units ("RSUs"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 900,000 RSUs vesting on November 1, 2023 and the balance vesting in 12 equal quarterly installments thereafter.
F3 Consists of (i) 10,702,720 Ordinary Shares underlying RSUs (which are represented by 1,337,840 ADSs); and (ii) 8,160,840 Ordinary Shares underlying 1,020,105 ADSs.